Actuality
News
Gate2Brain Receives EMA Orphan Drug Designation for Its Groundbreaking Pediatric Cancer Treatment
Gate2Brain, has reached a major milestone in the fight against pediatric brain tumors by obtaining Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for its innovative product, G2B-002.
Interviews
César Galo Garcia Fontecha
Head of the Orthopaedic Surgery and Traumatology Group
“Learning about what others are doing allows us to improve and develop new ideas in order to advance in the world of research.”
In 2022, the research team led by Dr. César Galo Garcia Fontecha joined the Sant Joan de Déu Research Institute as the “Orthopaedic Surgery and Traumatology” Group. We take a look at his scientific career up to the time he joined SJD Barcelona Children’s Hospital and the objectives of his new group.Agenda
i4KIDS | Pediatric Innovation Day Barcelona
Join us at the Pediatric Innovation Day in Barcelona! Discover cutting-edge advancements in paediatric healthcare and meet global experts.
#ViernesCientíficos | Diseño de un dispositivo de contención neonatal: Innovación enfermera
Seminario a cargo de Silvia Vicente Pérez. Enfermera Especialista en Pediatría. Experta en innovación en el ámbito de la salud y profesora titular de l'Escola Universitària d'Infermeria Sant Pau de Barcelona.
Communication area
Marta Fortuny
93 253 21 67
marta.fortuny@sjd.es